Experience

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by HubSpot, Inc. of $400 million aggregate principal amount of its 0.25% convertible senior notes due 2022,…

Davis Polk advised the joint book-running managers in connection with a $2.25 billion registered offering by Eli Lilly and Company of $750 million principal amount of its 2.350% notes…

Davis Polk advised the sole book-running manager on an SEC-registered offering by General Motors Financial Company, Inc. of $750 million aggregate principal amount of floating-rate senior…

Davis Polk advised Telefónica, S.A. and Telefónica Emisiones, S.A.U. on the SEC-registered $500 million aggregate principal amount off-the-shelf notes offering by Telefónica Emisiones, S.A…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $600 million aggregate principal amount of 2.750% notes due 2021 and 2.625% notes due 2024. The 2…

Davis Polk advised the initial purchasers in connection with a $600 million 5.25% Regulation S additional senior notes offering by Fortune Star (BVI) Limited, a wholly owned subsidiary of…

Davis Polk advised the joint lead managers in connection with the reopening of the Hashemite Kingdom of Jordan’s 6.125% notes due 2026 in the aggregate principal amount of $500 million…

Davis Polk advised the joint book-running managers in connection with the $225 million initial public offering of 15,000,000 shares of Class A common stock of Carvana Co. The Class A common…

Davis Polk advised The Orogen Group on its $108 million strategic equity investment in newly issued convertible preferred stock of Virtusa Corporation. In connection with the investment,…

Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Flexion Therapeutics, Inc. of $201.25 million aggregate principal amount of its 3.375% convertible…